These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25689528)

  • 41. Caspofungin.
    Parakh A; Dubey AP; Samanta D
    Indian Pediatr; 2008 Nov; 45(11):905-10. PubMed ID: 19029563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
    Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation.
    Trenschel R; Ditschkowski M; Elmaagacli AH; Koldehoff M; Ottinger H; Steckel N; Hlinka M; Peceny R; Rath PM; Dermoumi H; Beelen DW
    Bone Marrow Transplant; 2005 Mar; 35(6):583-6. PubMed ID: 15756283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
    Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A
    Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
    Shang W; Feng G; Sun R; Wang X; Liu W; Zhang S; Li J; Pang X; Wang Y; Zhang W
    J Clin Pharm Ther; 2012 Dec; 37(6):652-6. PubMed ID: 22725946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.
    Durand ML; Kim IK; D'Amico DJ; Loewenstein JI; Tobin EH; Kieval SJ; Martin SS; Azar DT; Miller FS; Lujan BJ; Miller JW
    Am J Ophthalmol; 2005 Sep; 140(3):552-4. PubMed ID: 16139017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Caspofungin for prophylaxis and treatment of fungal infections in adolescents and adults: a meta-analysis of randomized controlled trials.
    Yuan X; Wang R; Bai CQ; Song XJ; Liu YN
    Pharmazie; 2012 Apr; 67(4):267-73. PubMed ID: 22570929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients.
    Rieger CT; Ostermann H; Kolb HJ; Fiegl M; Huppmann S; Morgenstern N; Tischer J
    Ann Hematol; 2008 Nov; 87(11):915-22. PubMed ID: 18641986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-dose caspofungin as a component of combination antifungal therapy in 91 patients with neoplastic diseases and hematopoietic stem cell transplantation: a critical review of short-term and long-term adverse events.
    Safdar A; Rodriguez G; Zuniga J; Al Akhrass F; Pande A
    J Pharm Pract; 2015 Apr; 28(2):175-82. PubMed ID: 24366977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole.
    Hurtado-Sarrió M; Duch-Samper A; Cisneros-Lanuza A; Díaz-Llopis M; Peman-Garcíia J; Vazquez-Polo A
    Arch Ophthalmol; 2010 Jul; 128(7):941-2. PubMed ID: 20625061
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacokinetic and Pharmacodynamic Properties of Oral Voriconazole in Patients with Invasive Fungal Infections.
    Wang T; Xie J; Wang Y; Zheng X; Lei J; Wang X; Dong H; Yang Q; Chen L; Xing J; Dong Y
    Pharmacotherapy; 2015 Sep; 35(9):797-804. PubMed ID: 26406771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin.
    Tu EY
    Cornea; 2009 Jan; 28(1):116-9. PubMed ID: 19092423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality.
    Dignan FL; Evans SO; Ethell ME; Shaw BE; Davies FE; Dearden CE; Treleaven JG; Riley UB; Morgan GJ; Potter MN
    Bone Marrow Transplant; 2009 Jul; 44(1):51-6. PubMed ID: 19139735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
    Mandhaniya S; Swaroop C; Thulkar S; Vishnubhatla S; Kabra SK; Xess I; Bakhshi S
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):e333-41. PubMed ID: 22042283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.
    Madero L; Sanchez de Toledo J; Castel V; Sevilla J; Gonzalez-Esteban J; Sanz-Rodriguez C
    J Chemother; 2009 Apr; 21(2):229-31. PubMed ID: 19423481
    [No Abstract]   [Full Text] [Related]  

  • 57. [Tolerance of caspofungin in intensive care unit: a prospective study].
    Constantin JM; Roszyk L; Guerin R; Bannier F; Chartier C; Perbet S; Futier E; Cayot-Constantin S; Sapin V; Bazin JE
    Ann Fr Anesth Reanim; 2008 Oct; 27(10):819-24. PubMed ID: 18835682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
    Yunus S; Pieper S; Kolve H; Goletz G; Jürgens H; Groll AH
    J Antimicrob Chemother; 2014 Mar; 69(3):815-20. PubMed ID: 24198097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retrospective evaluation of caspofungin therapy in invasive aspergillosis (RECAM-IA).
    Wisniewski T; Klimko N; Laverdiere M; Kiertiburanakul S; Kliasova G; Trenschel R; Kumar RN
    Mycoses; 2011 Jul; 54(4):e148-53. PubMed ID: 20202110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful antifungal combination therapy with voriconazole and caspofungin.
    Schuster F; Moelter C; Schmid I; Graubner UB; Kammer B; Belohradsky BH; Führer M
    Pediatr Blood Cancer; 2005 Jun; 44(7):682-5. PubMed ID: 15700260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.